Hematopoietic stem cell proliferating agents
Patent Number: 6495365
Date of First Priority Issue: Tuesday August 12th, 1997
Date Issued: Tuesday December 17th, 2002
Assignee: Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)
Inventors: Saito, Yoshimasa (Kawanishi, JP); Ueda, Yoshiko (Osaka, JP); Tamura, Kouichi (Kobe, JP); Takata, Yoko (Osaka, JP); Yamada, Hisashi (Sanda, JP); Yamashita, Tatsuo (Kobe, JP); Kobayashi, Masakazu (Takarazuka, JP)
From Class: Expansion
Comments: No comments
This patent covers the use of IGF-1 (a protein that is already in the clinic) in combination with a protein selected from the group comprising of: G-CSF, M-CSF, or stem cell factor, for the stimulation of hematopoiesis.
This patent should be examined for the possibility of extending this technology to the area of other uses of hematopoietic stem cells. For example, will these combinations assist in hematopoietic stem cell repair of post infarct cardiac tissue?
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.